Severe Hyponatremia Case: SIADH, Seizure, SCLC | MDster                                                    You are offline 

     Back online! 

  [  MDster home ](/ "MDster home") 

  Specialities     [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics &amp; Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) 

 [ Features ](https://mdster.com/features) [ SOE Examiner NEW ](https://mdster.com/soe-examiner) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) 

 Menu      

  Specialities     [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics &amp; Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) 

 [ Features ](https://mdster.com/features) [ SOE Examiner NEW ](https://mdster.com/soe-examiner) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) 

 [     Login    ](https://mdster.com/auth/login) 

      1. [        Home  ](https://mdster.com)
2. [   Blog  ](https://mdster.com/blog)
3. [   Case Discussion  ](https://mdster.com/blog?category=case-discussion)
4. Severe Hyponatremia Case Discussion: SIADH, Seizures, and SCLC

  [ Case Discussion ](https://mdster.com/blog?category=case-discussion)  

 Severe Hyponatremia Case Discussion: SIADH, Seizures, and SCLC 
================================================================

  A board-focused walkthrough of symptomatic hyponatremia, hypertonic saline, overcorrection risk, and paraneoplastic SIADH

  [     MDster Editorial Team ](https://mdster.com/about) ·      Apr 15, 2026  ·      6 min read  ·       184  

  [     Reviewed by Dr. Ali Ragab, MBBCH, MSc, MCAI ](https://mdster.com/medical-reviewers/dr-ali-ragab) [Editorial Policy](https://mdster.com/editorial-policy) | [Corrections Policy](https://mdster.com/corrections) 

    [ Board Review ](https://mdster.com/blog?tag=board-review) [ Internal Medicine ](https://mdster.com/blog?tag=internal-medicine) [ Oncology ](https://mdster.com/blog?tag=oncology) [ Hyponatremia ](https://mdster.com/blog?tag=hyponatremia) [ SIADH ](https://mdster.com/blog?tag=siadh)  

                                                          ![Severe Hyponatremia Case Discussion: SIADH, Seizures, and SCLC](https://mdster.com/storage/blog/images/severe-hyponatremia-case-discussion-siadh-seizures-and-sclc.jpg)  

    Share this article 

        Share this post 

    On this page

 1. [ Framing the diagnosis ](#framing-the-diagnosis)
2. [ The first hour: treat the brain, not the number ](#the-first-hour-treat-the-brain-not-the-number)
3. [ Avoiding osmotic demyelination ](#avoiding-osmotic-demyelination)
4. [ After stabilization: managing persistent SIADH and the lung mass ](#after-stabilization-managing-persistent-siadh-and-the-lung-mass)
5. [ Clinical Application ](#clinical-application)
6. [ Key Points for Board Exams ](#key-points-for-board-exams)
7. [ Conclusion ](#conclusion)
8. [ Frequently Asked Questions ](#blog-faqs)
9. [ References ](#references-heading)

     On this page

 1. [ Framing the diagnosis ](#framing-the-diagnosis)
2. [ The first hour: treat the brain, not the number ](#the-first-hour-treat-the-brain-not-the-number)
3. [ Avoiding osmotic demyelination ](#avoiding-osmotic-demyelination)
4. [ After stabilization: managing persistent SIADH and the lung mass ](#after-stabilization-managing-persistent-siadh-and-the-lung-mass)
5. [ Clinical Application ](#clinical-application)
6. [ Key Points for Board Exams ](#key-points-for-board-exams)
7. [ Conclusion ](#conclusion)
8. [ Frequently Asked Questions ](#blog-faqs)
9. [ References ](#references-heading)

  A seizure with a **serum sodium of 108 mmol/L** is not a laboratory curiosity; it is a neurologic emergency. In this vignette, the bedside exam and the urine studies matter as much as the sodium itself. He is clinically euvolemic, hypo-osmolar, inappropriately concentrating his urine, and excreting urine sodium despite profound hyponatremia. Add a new hilar mass in a heavy smoker, and the working diagnosis is **severe symptomatic hypotonic euvolemic hyponatremia due to SIADH**, with **small-cell lung cancer (SCLC)** high on the list of causes. [\[1\]](#cite-1 "Reference [1]")

Framing the diagnosis
---------------------

The diagnostic move here is to classify the disorder before chasing the tumor. This patient meets the classic laboratory frame for SIADH: low effective serum osmolality, urine osmolality well above 100 mOsm/kg, urine sodium above 30 mmol/L, clinical euvolemia, and normal renal, thyroid, and adrenal function with no diuretic exposure. The confusion over three days argues that the hyponatremia is **duration-uncertain and likely chronic enough** that overcorrection is dangerous, even though the seizure demands immediate therapy. SCLC is the malignancy most classically associated with ectopic vasopressin secretion. [\[1\]](#cite-1 "Reference [1]")

PatternWhy it does not fit as well**Hypovolemic hyponatremia**Exam lacks volume depletion; urine sodium is not low.**Primary polydipsia/low-solute intake**Urine should be maximally dilute, not 520 mOsm/kg.**Adrenal insufficiency or hypothyroidism**Targeted testing is normal.

That table is the exam answer in miniature: this is **profound symptomatic SIADH until proved otherwise**. [\[1\]](#cite-1 "Reference [1]")

The first hour: treat the brain, not the number
-----------------------------------------------

Once seizure is attributed to hyponatremia, **3% hypertonic saline** is definitive therapy. European guidance recommends a **150 mL bolus over 20 minutes**, repeated as needed, aiming for about a **5 mmol/L rise** or clear neurologic improvement. The practical endpoint is not a normal sodium; it is interruption of cerebral edema physiology. Benzodiazepines may stop convulsive activity, but they do not correct the osmotic problem driving the seizure. Consequently, sodium correction has to begin immediately while diagnostic work continues in parallel. [\[1\]](#cite-1 "Reference [1]")

> **Clinical Pearl:** In severe hyponatremia, the emergency target is neurologic stabilization after a small sodium rise, not normalization. [\[1\]](#cite-1 "Reference [1]")

Monitoring is where experienced teams distinguish themselves. Early sodium checks every 2-4 hours are reasonable during active correction, and urine output should be watched closely. A sudden water diuresis is often the moment the case becomes dangerous, because sodium can then climb faster than planned. If symptoms improve after the initial rise, stop hypertonic saline and pivot to cause-specific management rather than chasing a prettier number. [\[1\]](#cite-1 "Reference [1]")

Avoiding osmotic demyelination
------------------------------

After the seizure stops, the main iatrogenic threat becomes **overcorrection**. Current guideline-based practice keeps the increase **below 10 mmol/L in the first 24 hours** and **below 8 mmol/L during each subsequent 24-hour period**; a commonly used expert ceiling is **no more than 18 mmol/L over 48 hours**. In patients at high risk for osmotic demyelination—alcohol use disorder, malnutrition, liver disease, hypokalemia, or very low starting sodium—clinical judgment usually favors an even slower target, often around **4-6 mmol/L per day**. [\[1\]](#cite-1 "Reference [1]")

If sodium begins to outrun the plan, stop active therapy. Many centers then use **desmopressin with electrolyte-free water** to halt or reverse overcorrection, particularly when brisk aquaresis has started. ODS is often delayed, appearing after initial improvement, so the team should remain suspicious if dysarthria, dysphagia, spasticity, or new quadriparesis emerge days later. [\[2\]](#cite-2 "Reference [2]")

After stabilization: managing persistent SIADH and the lung mass
----------------------------------------------------------------

For ongoing SIADH, **fluid restriction** remains first-line. If that fails, the European guideline favors **urea** or **low-dose loop diuretic plus oral sodium chloride** as second-line strategies. It is worth knowing the nuance: older teaching and many board-style discussions still mention **demeclocycline** and **tolvaptan**, but major European guidance recommends against routine demeclocycline and against vasopressin antagonists in moderate/profound hyponatremia because harm can outweigh benefit. [\[1\]](#cite-1 "Reference [1]")

Tolvaptan nevertheless remains relevant in real practice because the **FDA labeling** allows it for clinically significant **euvolemic or hypervolemic hyponatremia** that is symptomatic or resistant to fluid restriction. The catch is safety: it is **not** for urgent rescue, must be **started in hospital**, requires close sodium monitoring, **fluid restriction should be avoided during the first 24 hours**, patients must be able to drink to thirst, concomitant hypertonic saline is not recommended, and therapy is generally limited to **30 days** because of hepatotoxicity risk. [\[3\]](#cite-3 "Reference [3]")

The chest X-ray should be communicated carefully. A post-ictal, hyponatremic patient may not yet have decision-making capacity. Ethically, involve him as capacity returns; if he lacks capacity, speak with the appropriate surrogate, explain that the film shows a **mass requiring CT and tissue diagnosis**, and avoid premature certainty while still naming the concern. [\[4\]](#cite-4 "Reference [4]")

Clinical Application
--------------------

In real admissions, the common error is to separate the seizure from the sodium and the sodium from the malignancy. The better frame is integrated: **stabilize the brain with hypertonic saline, prevent overcorrection, confirm SIADH biochemically, and investigate the likely thoracic source quickly**. In paraneoplastic SIADH, durable control often follows successful cancer therapy more than any electrolyte maneuver. [\[5\]](#cite-5 "Reference [5]")

Key Points for Board Exams
--------------------------

- **Seizure + Na 108 mmol/L = severe symptomatic hypotonic hyponatremia needing immediate hypertonic saline.** [\[1\]](#cite-1 "Reference [1]")
- **SIADH is supported by low serum osmolality, Uosm &gt;100, urine Na &gt;30, euvolemia, and exclusion of adrenal/thyroid/renal failure.** [\[1\]](#cite-1 "Reference [1]")
- **Aim for an initial 4-6 or roughly 5 mmol/L rise to reverse symptoms, not full normalization.** [\[1\]](#cite-1 "Reference [1]")
- **Avoid overcorrection: &lt;10 mmol/L in 24 h, then &lt;8 mmol/L per 24 h thereafter; many experts also use &lt;18 mmol/L in 48 h.** [\[1\]](#cite-1 "Reference [1]")
- **In a smoker with a hilar mass, think paraneoplastic SIADH from SCLC until proven otherwise.** [\[5\]](#cite-5 "Reference [5]")

Conclusion
----------

This is a classic board and bedside case because it rewards disciplined physiology. The diagnosis is SIADH, the emergency drug is **3% saline**, the feared complication is **osmotic demyelination from overcorrection**, and the hidden driver is probably **thoracic malignancy**. Manage all four threads at once, and the case becomes much safer. [\[1\]](#cite-1 "Reference [1]")

    Frequently Asked Questions 
----------------------------

 ###     Why is this classified as euvolemic rather than hypovolemic hyponatremia?             

Because the patient is clinically euvolemic and has urine sodium above 30 mmol/L with concentrated urine despite hypo-osmolality, a pattern that fits SIADH far better than volume depletion. [\[1\]](#cite-1 "Reference [1]")

###     What sodium rise should I target in the first few hours of a hyponatremic seizure?             

Target a small early rise—about 4-6 mmol/L or roughly 5 mmol/L—to reverse cerebral edema and stop severe symptoms. [\[1\]](#cite-1 "Reference [1]")

###     When should I worry most about osmotic demyelination?             

Risk rises when chronic or duration-uncertain hyponatremia is corrected too quickly, especially in patients with alcoholism, malnutrition, liver disease, hypokalemia, or very low starting sodium. [\[6\]](#cite-6 "Reference [6]")

###     Can tolvaptan be used for this patient after the acute phase?             

Sometimes, but selectively: it is not for urgent neurologic rescue, should be initiated in hospital, requires close sodium monitoring, and carries rapid-correction and hepatotoxicity risks. [\[3\]](#cite-3 "Reference [3]")

        References  (8)  
------------------

 1. 1.  [ Spasovski G, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. European Journal of Endocrinology. 2014.     ](https://academic.oup.com/ejendo/article/170/3/G1/6668028)   [↩](#cite-ref-1-1 "Back to text")
2. 2.  [ pmc.ncbi.nlm.nih.gov/articles/PMC7015090     ](https://pmc.ncbi.nlm.nih.gov/articles/PMC7015090/)   [↩](#cite-ref-2-1 "Back to text")
3. 3.  [ SAMSCA (tolvaptan) prescribing information.     ](https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022275s017lbl.pdf)   [↩](#cite-ref-3-1 "Back to text")
4. 4.  [ AMA Code of Medical Ethics Opinion 2.1.2: Decisions for Adult Patients Who Lack Capacity.     ](https://code-medical-ethics.ama-assn.org/sites/amacoedb/files/2022-08/2.1.2_1.pdf)   [↩](#cite-ref-4-1 "Back to text")
5. 5.  [ www.ncbi.nlm.nih.gov/sites/books/NBK279135     ](https://www.ncbi.nlm.nih.gov/sites/books/NBK279135/)   [↩](#cite-ref-5-1 "Back to text")
6. 6.  [ Sterns RH, Silver SM. Treatment Guidelines for Hyponatremia: Stay the Course. Clinical Journal of the American Society of Nephrology. 2024.     ](https://pmc.ncbi.nlm.nih.gov/articles/PMC10843202/)   [↩](#cite-ref-6-1 "Back to text")
7. 7.  [ FDA Drug Safety Communication: FDA limits duration and usage of Samsca (tolvaptan) due to possible liver injury leading to organ transplant or death.     ](https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-limits-duration-and-usage-samsca-tolvaptan-due-possible-liver)
8. 8.  [ Kaltsas G, et al. Paraneoplastic Syndromes Related to Neuroendocrine Tumors. Endotext.     ](https://www.ncbi.nlm.nih.gov/books/NBK279135/)

Keep going

 Turn reading into Internal Medicine performance 
-------------------------------------------------

 - System‑based, exam‑style questions + explanations
- Smarter review to reinforce weak topics
- Build confidence with measurable progress

 [     Start practicing ](https://mdster.com/user/dashboard)  [     Explore Internal Medicine ](https://mdster.com/speciality/internal-medicine)  

   [ View pricing ](https://mdster.com/pricing) [ Explore features ](https://mdster.com/features)  

  No credit card required. Full access to all features\*. No commitment. Cancel anytime.

 \*AI SOE Examiner is limited to 10 cases monthly for Advanced &amp; Bundle subscribers.

   Explore topics:  [ # Board Review ](https://mdster.com/blog?tag=board-review) [ # Internal Medicine ](https://mdster.com/blog?tag=internal-medicine) [ # Oncology ](https://mdster.com/blog?tag=oncology) [ # Hyponatremia ](https://mdster.com/blog?tag=hyponatremia) [ # SIADH ](https://mdster.com/blog?tag=siadh)  

  [     Back to all posts ](https://mdster.com/blog) 

       Discussion  ()  
-----------------

        Join the discussion

 [     Log in ](https://mdster.com/auth/login) or [     Sign up ](https://mdster.com/auth/register) 

       No comments yet

Be the first to share your thoughts!

    ![]()     

       More in Case Discussion
-----------------------

 [ See all     ](https://mdster.com/blog?category=case-discussion) 

  [###  Resuscitative Thoracotomy in Penetrating Cardiac Tamponade 

      7 min read       Jul 14, 2026

     ](https://mdster.com/blog/resuscitative-thoracotomy-in-penetrating-cardiac-tamponade) [###  Placental Abruption After Minor Trauma: A 34-Week Case Discussion 

      8 min read       Jul 12, 2026

     ](https://mdster.com/blog/placental-abruption-after-minor-trauma-a-34-week-case-discussion)  

        Related Posts
-------------

  [                                ![Adolescent Confidentiality and Risk Prevention in Family Medicine](https://mdster.com/storage/blog/images/adolescent-confidentiality-and-risk-prevention-in-family-medicine.jpg)         Medical Education 

###  Adolescent Confidentiality and Risk Prevention in Family Medicine 

 A practical, board-focused guide to adolescent confidentiality, injury prevention, sexual health, substance use, and mental health screening in Family Medicine.

     7 min read 

     0 comments 

 ](https://mdster.com/blog/adolescent-confidentiality-and-risk-prevention-in-family-medicine) [                                ![Resuscitative Thoracotomy in Penetrating Cardiac Tamponade](https://mdster.com/storage/blog/images/resuscitative-thoracotomy-in-penetrating-cardiac-tamponade.jpg)         Case Discussion 

###  Resuscitative Thoracotomy in Penetrating Cardiac Tamponade 

 A high-yield Emergency Medicine case discussion on ED thoracotomy for stab-related cardiac tamponade, including indications, technique, futility, and exam pearls.

     7 min read 

     0 comments 

 ](https://mdster.com/blog/resuscitative-thoracotomy-in-penetrating-cardiac-tamponade) [                                ![Tumor Lysis Syndrome Risk Assessment: Spot the Patient at Risk](https://mdster.com/storage/blog/images/tumor-lysis-syndrome-risk-assessment-spot-the-patient-at-risk.jpg)         Medical Education 

###  Tumor Lysis Syndrome Risk Assessment: Spot the Patient at Risk 

 A focused Internal Medicine review of TLS risk assessment, with high-yield emphasis on renal dysfunction, tumor burden, chemosensitivity, and high-risk leukemias/lymphomas.

     7 min read 

     0 comments 

 ](https://mdster.com/blog/tumor-lysis-syndrome-risk-assessment-spot-the-patient-at-risk) [                                ![Precocious and Delayed Puberty: Bone Age, Patterns, Referral](https://mdster.com/storage/blog/images/precocious-and-delayed-puberty-bone-age-patterns-referral.jpg)         Medical Education 

###  Precocious and Delayed Puberty: Bone Age, Patterns, Referral 

 A board-focused pediatrics review of how bone age, growth velocity, and pubertal pattern separate central from peripheral causes—and when endocrine referral should be urgent.

     7 min read 

     0 comments 

 ](https://mdster.com/blog/precocious-and-delayed-puberty-bone-age-patterns-referral) [                                ![Placental Abruption After Minor Trauma: A 34-Week Case Discussion](https://mdster.com/storage/blog/images/placental-abruption-after-minor-trauma-a-34-week-case-discussion.jpg)         Case Discussion 

###  Placental Abruption After Minor Trauma: A 34-Week Case Discussion 

 A board-focused case discussion on evaluating minor blunt trauma at 34 weeks, recognizing placental abruption, timing fetal monitoring, and dosing Rh immune globulin.

     8 min read 

     0 comments 

 ](https://mdster.com/blog/placental-abruption-after-minor-trauma-a-34-week-case-discussion) [                                ![Mandatory Disclosures in the ED: When Confidentiality Yields](https://mdster.com/storage/blog/images/mandatory-disclosures-in-the-ed-when-confidentiality-yields.jpg)         Medical Education 

###  Mandatory Disclosures in the ED: When Confidentiality Yields 

 In the ED, missing a required disclosure can harm patients and expose clinicians. Review child abuse reporting, reportable diseases, and medically impaired driving.

     7 min read 

     0 comments 

 ](https://mdster.com/blog/mandatory-disclosures-in-the-ed-when-confidentiality-yields)  

  [  MDster home ](/ "MDster home") Master your medical exams with evidence-based learning.

 [       GET IT ON Google Play 

 ](https://play.google.com/store/apps/details?id=com.mdster.app) 

Platform

- [Home](https://mdster.com)
- [Features](https://mdster.com/features)
- [Pricing](https://mdster.com/pricing)
- [About](https://mdster.com/about)

Resources

- [Blog](https://mdster.com/blog)
- [Dashboard](https://mdster.com/user/dashboard)

Support

- [Contact](https://mdster.com/contact)
- [Legal &amp; Policies](https://mdster.com/legal)
- [Medical Reviewers](https://mdster.com/medical-reviewers)

 © 2026 MDster

 [    ](https://play.google.com/store/apps/details?id=com.mdster.app) [Terms](https://mdster.com/terms) [Privacy](https://mdster.com/privacy) [Editorial](https://mdster.com/editorial-policy) 

     reCAPTCHA  Protected by reCAPTCHA.

 Google [Privacy Policy](https://policies.google.com/privacy) and [Terms of Service](https://policies.google.com/terms) apply.

Cookie Consent
--------------

 We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. [ Terms of Use ](https://mdster.com/terms) &amp; [ Privacy Policy ](https://mdster.com/privacy)

  Accept
